|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000068650 |
Summary for ATP11A |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000068650 | Gene symbol | ATP11A |
| Gene name | ATPase phospholipid transporting 11A | |
| HGNC | 13552 | |
| Entrez ID | 23250 | |
| Gene type | protein_coding | |
| Synonyms | ATP11A|ATPIH|ATPIS|KIAA1021 | |
| UniProtAcc | P98196 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for ATP11A |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ATP11A | 3.94e+03 | 1.53e+00 | 4.15e-01 | 3.68e+00 | 2.30e-04 | 9.26e-04 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ATP11A | 1.59e+03 | 1.06e+00 | 3.60e-01 | 2.93e+00 | 3.35e-03 | 2.11e-02 | BLCA |
| ATP11A | 2.81e+03 | -1.38e+00 | 2.85e-01 | -4.83e+00 | 1.34e-06 | 4.94e-06 | KICH |
| ATP11A | 3.79e+03 | 2.58e+00 | 3.81e-01 | 6.78e+00 | 1.24e-11 | 4.28e-10 | READ |
Top |
Sex-biased somatic mutation for ATP11A |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for ATP11A |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUSC | cg03992114 | chr13:112689062 | CGI:chr13:112689539-112690874 | promoter | 5.54e-01 | 3.85e-01 | 2.60e+00 | 9.19e-03 | 1.30e-02 | 1.70e-01 |
| LUSC | cg20708856 | chr13:112691943 | CGI:chr13:112689539-112690874 | promoter,gene body | 6.49e-01 | 4.82e-01 | 3.19e+00 | 1.41e-03 | 3.27e-03 | 1.66e-01 |
| LUSC | cg01025720 | chr13:112692125 | CGI:chr13:112689539-112690874 | promoter,gene body | 8.21e-01 | 5.80e-01 | 3.80e+00 | 1.44e-04 | 8.22e-04 | 2.41e-01 |
| LUSC | cg07610853 | chr13:112692302 | CGI:chr13:112689539-112690874 | promoter,gene body | 6.84e-01 | 4.80e-01 | 3.61e+00 | 3.09e-04 | 1.24e-03 | 2.03e-01 |
| COAD | cg07610853 | chr13:112692302 | CGI:chr13:112689539-112690874 | promoter,gene body | 5.93e-01 | 7.23e-01 | -2.87e+00 | 4.07e-03 | 7.00e-03 | -1.30e-01 |
| BLCA | cg23049429 | chr13:112691630 | CGI:chr13:112689539-112690874 | promoter,gene body | 1.01e-01 | 2.03e-01 | -3.94e+00 | 8.29e-05 | 3.50e-04 | -1.02e-01 |
| BLCA | cg03992114 | chr13:112689062 | CGI:chr13:112689539-112690874 | promoter | 4.97e-01 | 6.79e-01 | -2.70e+00 | 7.03e-03 | 1.07e-02 | -1.82e-01 |
| BLCA | cg20708856 | chr13:112691943 | CGI:chr13:112689539-112690874 | promoter,gene body | 6.66e-01 | 7.80e-01 | -2.40e+00 | 1.62e-02 | 2.07e-02 | -1.13e-01 |
| KIRP | cg03992114 | chr13:112689062 | CGI:chr13:112689539-112690874 | promoter | 7.18e-01 | 8.20e-01 | -2.31e+00 | 2.09e-02 | 2.39e-02 | -1.02e-01 |
| KIRP | cg01025720 | chr13:112692125 | CGI:chr13:112689539-112690874 | promoter,gene body | 5.67e-01 | 7.35e-01 | -3.32e+00 | 9.10e-04 | 1.68e-03 | -1.68e-01 |
| CHOL | cg20708856 | chr13:112691943 | CGI:chr13:112689539-112690874 | promoter,gene body | 3.92e-01 | 7.36e-01 | -3.54e+00 | 4.02e-04 | 8.32e-03 | -3.43e-01 |
| CHOL | cg01025720 | chr13:112692125 | CGI:chr13:112689539-112690874 | promoter,gene body | 5.58e-01 | 8.94e-01 | -3.10e+00 | 1.96e-03 | 1.07e-02 | -3.36e-01 |
| CHOL | cg07610853 | chr13:112692302 | CGI:chr13:112689539-112690874 | promoter,gene body | 4.23e-01 | 7.31e-01 | -3.10e+00 | 1.96e-03 | 1.07e-02 | -3.09e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUAD | cg03992114 | chr13:112689062 | CGI:chr13:112689539-112690874 | promoter | 2.73e-01 | 4.15e-01 | -3.04e+00 | 2.37e-03 | 5.73e-03 | -1.42e-01 |
| LIHC | cg20708856 | chr13:112691943 | CGI:chr13:112689539-112690874 | promoter,gene body | 6.44e-01 | 7.85e-01 | -3.06e+00 | 2.25e-03 | 4.27e-03 | -1.42e-01 |
Top |
Exon skipping events with PSI in TCGA for ATP11A |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| STAD | exon_skip_101464 | 1.88e-01 | 3.14e-01 | -4.90e+00 | 9.63e-07 | 7.97e-05 | -1.26e-01 |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for ATP11A |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for ATP11A |
| TFs related to ATP11A. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ATP11A related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for ATP11A |
| RBPs related to ES in ATP11A. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| COAD | ZC3H10 | exon_skip_101451 | 7.28e+00 | 7.39e-03 | 7.64e+00 | 9.83e-01 | Female-biased |
| READ | PABPC3 | exon_skip_101445 | 9.95e+00 | 1.81e-02 | 1.02e+01 | 9.80e-01 | Female-biased |
| READ | ZC3H10 | exon_skip_101451 | 7.66e+00 | 9.84e-01 | 7.29e+00 | 6.05e-03 | Male-biased |
| THCA | ZC3H10 | exon_skip_101451 | 7.61e+00 | 9.88e-01 | 7.20e+00 | 1.94e-03 | Male-biased |
| LGG | ZC3H10 | exon_skip_101451 | 7.77e+00 | 9.90e-01 | 7.18e+00 | 8.07e-04 | Male-biased |
| ATP11A related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000068650 | AC004943.2,hsa-mir-202,ATP11A | Female-specific ceRNA | TCGA-BLCA |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs7330879 | chr13:112768140:A:G | gene | -0.0657116748052272 | 0.00466529149827099 | THCA | Female-baised eQTL |
| rs2163996 | chr13:112784143:T:C | gene | -0.0612670379733581 | 0.0127007306824132 | THCA | Female-baised eQTL |
| rs748467 | chr13:112770159:T:A | gene | -0.0598821112665857 | 0.0169779085839446 | THCA | Female-baised eQTL |
| rs2094809 | chr13:112770635:T:C | gene | -0.0591776046330206 | 0.0191488605549784 | THCA | Female-baised eQTL |
| rs185820 | chr13:112770774:T:G | gene | -0.0589486958115982 | 0.0213157251229055 | THCA | Female-baised eQTL |
| rs2094810 | chr13:112770784:C:G | gene | -0.0589486958115982 | 0.0213157251229055 | THCA | Female-baised eQTL |
| rs914023 | chr13:112770079:A:G | gene | -0.0592704181273321 | 0.0228113252880367 | THCA | Female-baised eQTL |
| rs447590 | chr13:112792897:A:C | gene | -0.0578920057067063 | 0.0277533536250752 | THCA | Female-baised eQTL |
| rs431106 | chr13:112797406:C:A | gene | -0.0572140521813501 | 0.0350553656517927 | THCA | Female-baised eQTL |
| rs9603948 | chr13:112783706:C:A | gene | -0.0574299781924314 | 0.0361563425806079 | THCA | Female-baised eQTL |
| rs61961156 | chr13:112779420:T:A | gene | -0.0571416077350011 | 0.0407458185850635 | THCA | Female-baised eQTL |
| rs74123524 | chr13:109186107:A:G | - | 0.0952036919376175 | 0.00510038418979611 | SARC | Female-baised eQTL |
| rs74123526 | chr13:109186979:T:C | - | 0.0952036919376175 | 0.00510038418979611 | SARC | Female-baised eQTL |
| rs74123528 | chr13:109190409:T:C | - | 0.0952036919376175 | 0.00510038418979611 | SARC | Female-baised eQTL |
| rs55935772 | chr13:109193279:A:G | - | 0.0950535802188197 | 0.00530980944847871 | SARC | Female-baised eQTL |
| rs76063436 | chr13:109780785:C:T | - | 0.128125551241366 | 0.0019791960023628 | LGG | Female-baised eQTL |
| rs76141819 | chr13:109780883:A:C | - | 0.128125551241366 | 0.0019791960023628 | LGG | Female-baised eQTL |
| rs78005022 | chr13:109778551:A:G | - | 0.127489600078411 | 0.00223249573888578 | LGG | Female-baised eQTL |
| rs12585507 | chr13:109780189:T:C | - | 0.127489600078411 | 0.00223249573888578 | LGG | Female-baised eQTL |
| rs77719795 | chr13:109799559:G:A | - | 0.122759244372461 | 0.00292679888946611 | LGG | Female-baised eQTL |
| rs79323307 | chr13:109748152:G:A | - | 0.132551413548098 | 0.0037079113948269 | LGG | Female-baised eQTL |
| rs75423791 | chr13:109750467:T:A | - | 0.13253984148701 | 0.0037359312681838 | LGG | Female-baised eQTL |
| rs75584993 | chr13:109758178:A:C | - | 0.129346508690661 | 0.00497227980203997 | LGG | Female-baised eQTL |
| rs75294247 | chr13:109758245:T:C | - | 0.129346508690661 | 0.00497227980203997 | LGG | Female-baised eQTL |
| rs112759492 | chr13:109758542:T:C | - | 0.129346508690661 | 0.00497227980203997 | LGG | Female-baised eQTL |
| rs75908536 | chr13:109760688:C:A | - | 0.129346508690661 | 0.00497227980203997 | LGG | Female-baised eQTL |
| rs74789436 | chr13:109761085:G:A | - | 0.129346508690661 | 0.00497227980203997 | LGG | Female-baised eQTL |
| rs75031974 | chr13:109795962:G:T | - | 0.117923994418408 | 0.00504965992714747 | LGG | Female-baised eQTL |
| rs80326876 | chr13:109761859:C:T | - | 0.126611806154271 | 0.00615961356928901 | LGG | Female-baised eQTL |
| rs79891016 | chr13:109763632:G:A | - | 0.126611806154271 | 0.00615961356928901 | LGG | Female-baised eQTL |
| rs77419996 | chr13:109767274:G:A | - | 0.123959231676995 | 0.00641765827061086 | LGG | Female-baised eQTL |
| rs12584954 | chr13:109772872:T:A | - | 0.12733451846359 | 0.00652267694965576 | LGG | Female-baised eQTL |
| rs1044364 | chr13:109755299:T:C | - | 0.119781957146315 | 0.0106399607610313 | LGG | Female-baised eQTL |
| rs76944188 | chr13:109748957:T:C | - | 0.11968535020869 | 0.0125330183440857 | LGG | Female-baised eQTL |
| rs12584136 | chr13:109767007:C:A | - | 0.111694974874029 | 0.0185513035432169 | LGG | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4438160 | chr13:108108467:T:G | - | -0.179404068292855 | 0.0309550465298517 | SARC | Male-baised eQTL |
| rs1931352 | chr13:108117599:C:T | - | -0.179404068292855 | 0.0309550465298517 | SARC | Male-baised eQTL |
| rs7492089 | chr13:104165916:G:A | - | 0.0794262646504504 | 0.00598265347510699 | LIHC | Male-baised eQTL |
| rs1923870 | chr13:104166822:C:T | - | 0.0794262646504504 | 0.00598265347510699 | LIHC | Male-baised eQTL |
| rs9514229 | chr13:104163211:G:C | - | 0.0674176308031427 | 0.0287050240583075 | LIHC | Male-baised eQTL |
| rs8002403 | chr13:108737122:C:A | - | -0.0565701952778267 | 0.00357951021692421 | KIRC | Male-baised eQTL |
| rs4772989 | chr13:108738408:G:C | - | -0.0565900747287979 | 0.00376881075395594 | KIRC | Male-baised eQTL |
| rs7981047 | chr13:108737517:A:T | - | -0.0562099700949845 | 0.00391991104031842 | KIRC | Male-baised eQTL |
| rs143665753 | chr13:108739171:T:C | - | -0.0562099700949845 | 0.00391991104031842 | KIRC | Male-baised eQTL |
| rs9521000 | chr13:108739300:T:C | - | -0.0562099700949845 | 0.00391991104031842 | KIRC | Male-baised eQTL |
| rs117067409 | chr13:108739262:C:A | - | -0.0506688168265677 | 0.00484704995770517 | KIRC | Male-baised eQTL |
| rs9301312 | chr13:108740547:T:C | - | -0.0553650668219082 | 0.00517206309869856 | KIRC | Male-baised eQTL |
| rs9521001 | chr13:108739361:A:C | - | -0.0552675688606237 | 0.00665011500655298 | KIRC | Male-baised eQTL |
| rs9515163 | chr13:110192649:A:G | - | 0.0518270306668909 | 0.0181480996222941 | KIRC | Male-baised eQTL |
| rs1223623 | chr13:107500547:G:C | - | 0.0421997096095668 | 0.0379166928073684 | KIRC | Male-baised eQTL |
| rs28417063 | chr13:107500655:G:T | - | 0.0421493027733396 | 0.0380576583438578 | KIRC | Male-baised eQTL |
| rs55657974 | chr13:107503989:C:G | - | 0.0416285854571902 | 0.0480510623076808 | KIRC | Male-baised eQTL |
| rs72658291 | chr13:109251123:T:C | - | 0.0993154326612892 | 0.00468497378881106 | COAD | Male-baised eQTL |
| rs331597 | chr13:110553776:C:T | - | -0.0892771891036481 | 0.00695528779201781 | COAD | Male-baised eQTL |
| rs12866244 | chr13:103377779:A:C | - | 0.0861075011920722 | 0.00759218935419878 | COAD | Male-baised eQTL |
| rs9559833 | chr13:110509905:G:A | - | 0.109128954139006 | 0.00949365064207454 | COAD | Male-baised eQTL |
| rs79169857 | chr13:107569988:T:G | - | 0.108356796011262 | 0.0101369732342765 | COAD | Male-baised eQTL |
| rs7325754 | chr13:107571341:G:A | - | 0.108356796011262 | 0.0101369732342765 | COAD | Male-baised eQTL |
| rs9554911 | chr13:102939986:G:A | - | 0.0801314977546009 | 0.0102140821181629 | COAD | Male-baised eQTL |
| rs5004533 | chr13:103379622:T:A | - | 0.0811492621390553 | 0.0102917462484169 | COAD | Male-baised eQTL |
| rs12859224 | chr13:103378061:T:A | - | 0.0801543825708342 | 0.0114580450652092 | COAD | Male-baised eQTL |
| rs10508109 | chr13:103378342:A:G | - | 0.0801543825708342 | 0.0114580450652092 | COAD | Male-baised eQTL |
| rs9582695 | chr13:103384086:A:G | - | 0.078802127500082 | 0.0151131700948224 | COAD | Male-baised eQTL |
| rs12427708 | chr13:110513246:G:A | - | 0.10785945160343 | 0.0152694879620662 | COAD | Male-baised eQTL |
| rs9300811 | chr13:103383961:T:C | - | 0.0777796401916769 | 0.0168353058324443 | COAD | Male-baised eQTL |
| rs7332082 | chr13:107563233:T:C | - | 0.0980145691906043 | 0.0182052234112023 | COAD | Male-baised eQTL |
| rs74388208 | chr13:107569976:A:T | - | 0.100945778751673 | 0.0193168209874546 | COAD | Male-baised eQTL |
| rs12584125 | chr13:102953877:G:A | - | 0.0765879083337596 | 0.0200826936389988 | COAD | Male-baised eQTL |
| rs7332705 | chr13:107563545:T:G | - | 0.0967677034802728 | 0.0228999317562458 | COAD | Male-baised eQTL |
| rs73593171 | chr13:107572352:C:A | - | 0.0972734324214051 | 0.0240342981796319 | COAD | Male-baised eQTL |
| rs11616438 | chr13:106784656:G:A | - | 0.127223102511261 | 0.0265007548350567 | COAD | Male-baised eQTL |
| rs9558721 | chr13:106203817:T:A | - | 0.0801527732468999 | 0.0267925639596409 | COAD | Male-baised eQTL |
| rs9587505 | chr13:108095383:A:G | - | 0.070722582465687 | 0.0301428539680393 | COAD | Male-baised eQTL |
| rs9557972 | chr13:102971119:C:T | - | 0.0707284165236058 | 0.0301554178813919 | COAD | Male-baised eQTL |
| rs77216858 | chr13:102971900:C:T | - | 0.0706522275592186 | 0.0302969458736947 | COAD | Male-baised eQTL |
| rs9557973 | chr13:102979299:T:A | - | 0.0706522275592186 | 0.0302969458736947 | COAD | Male-baised eQTL |
| rs75279911 | chr13:102979551:C:T | - | 0.0706522275592186 | 0.0302969458736947 | COAD | Male-baised eQTL |
| rs1529634 | chr13:102998297:T:G | - | 0.0706522275592186 | 0.0302969458736947 | COAD | Male-baised eQTL |
| rs3886168 | chr13:107573420:C:T | - | 0.0930487953514716 | 0.0335310152983227 | COAD | Male-baised eQTL |
| rs9557985 | chr13:103006296:G:T | - | 0.0672337630606998 | 0.0350328866720562 | COAD | Male-baised eQTL |
| rs9557978 | chr13:102985637:C:T | - | 0.0695498934126896 | 0.0353155895153601 | COAD | Male-baised eQTL |
| rs9557981 | chr13:102992925:T:G | - | 0.0693763797405854 | 0.0361476366053988 | COAD | Male-baised eQTL |
| rs9558119 | chr13:103574917:C:T | - | 0.0991282894892033 | 0.0425437936831325 | COAD | Male-baised eQTL |
| rs16969822 | chr13:107190273:T:A | - | 0.0723975881934786 | 0.0440277831386872 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000068650 |
| CpG Site: cg03044444 | |
| Position to Gene: gene | |
| Male Effect: -0.298599590022094 | |
| Female Effect: - | |
 | Gene ID: ENSG00000068650 |
| CpG Site: cg09731211 | |
| Position to Gene: gene | |
| Male Effect: -0.416557742350687 | |
| Female Effect: - | |
 | Gene ID: ENSG00000068650 |
| CpG Site: cg14649073 | |
| Position to Gene: gene | |
| Male Effect: -0.416557742350687 | |
| Female Effect: - | |
 | Gene ID: ENSG00000068650 |
| CpG Site: cg14381255 | |
| Position to Gene: gene | |
| Male Effect: -0.416557742350687 | |
| Female Effect: - | |
 | Gene ID: ENSG00000068650 |
| CpG Site: cg25440131 | |
| Position to Gene: gene | |
| Male Effect: -0.209208586118209 | |
| Female Effect: - | |
 | Gene ID: ENSG00000068650 |
| CpG Site: cg01025720 | |
| Position to Gene: gene,promoter | |
| Male Effect: -0.126572307990963 | |
| Female Effect: - | |
 | Gene ID: ENSG00000068650 |
| CpG Site: cg17900127 | |
| Position to Gene: gene | |
| Male Effect: -0.190861715458242 | |
| Female Effect: - | |
 | Gene ID: ENSG00000068650 |
| CpG Site: cg14845609 | |
| Position to Gene: gene | |
| Male Effect: -0.294047849963087 | |
| Female Effect: - | |
 | Gene ID: ENSG00000068650 |
| CpG Site: cg17218041 | |
| Position to Gene: gene | |
| Male Effect: -0.241616244571553 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg03044444 | chr13:112701042 | gene | -0.298599590022094 | 2.75385821977029e-13 | -0.5291492971500401 | 6.724252043281833e-16 | KIRP |
| cg09731211 | chr13:112700335 | gene | -0.416557742350687 | 1.23498260096975e-12 | -0.5212921971464565 | 2.1205504804574968e-15 | KIRP |
| cg14649073 | chr13:112782804 | gene | -0.416557742350687 | 1.23498260096975e-12 | -0.5212921971464565 | 2.1205504804574968e-15 | KIRP |
| cg14381255 | chr13:112782900 | gene | -0.416557742350687 | 1.23498260096975e-12 | -0.5212921971464565 | 2.1205504804574968e-15 | KIRP |
| cg25440131 | chr13:112730268 | gene | -0.209208586118209 | 7.53310794687428e-06 | -0.36528152142999726 | 9.721148623790077e-08 | KIRP |
| cg01025720 | chr13:112692125 | gene,promoter | -0.126572307990963 | 3.65917205650439e-05 | -0.35265443171818567 | 2.8293301340447933e-07 | KIRP |
| cg17900127 | chr13:112729187 | gene | -0.190861715458242 | 9.60846542989475e-05 | -0.35558665350061885 | 2.2167982249767196e-07 | KIRP |
| cg14845609 | chr13:112721696 | gene | -0.294047849963087 | 1.59102316068029e-05 | -0.36486702022698625 | 1.9919213410988767e-08 | LUAD |
| cg17218041 | chr13:112711005 | gene | -0.241616244571553 | 5.64068454808162e-05 | -0.348732317464186 | 8.931005212509595e-08 | LUAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of ATP11A |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000068650 | ATP11A | C1800706 | Idiopathic Pulmonary Fibrosis | 1 | CTD_human |
| ENSG00000068650 | ATP11A | C4721508 | Hamman-Rich Disease | 1 | CTD_human |
| ENSG00000068650 | ATP11A | C4721509 | Usual Interstitial Pneumonia | 1 | CTD_human |
| ENSG00000068650 | ATP11A | C4721952 | Familial Idiopathic Pulmonary Fibrosis | 1 | CTD_human |
